Quick Answer
GLOBUS MEDICAL INC reported Total Revenue of $2.94 billion for fiscal year 2025.
GLOBUS MEDICAL INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.94B +16.7% |
$2.52B +60.6% |
$1.57B +53.3% |
$1.02B +6.8% |
$958.10M +21.4% |
$789.04M +0.5% |
| Net Income | $537.87M +422.3% |
$102.98M -16.2% |
$122.87M -35.4% |
$190.17M +27.5% |
$149.19M +45.9% |
$102.28M -34.1% |
| Diluted EPS | $3.92 +422.7% |
$0.75 -29.9% |
$1.07 -42.2% |
$1.85 +28.5% |
$1.44 +42.6% |
$1.01 -33.6% |
| Total Assets | $5.30B +1.0% |
$5.25B +3.3% |
$5.09B +145.0% |
$2.08B +6.1% |
$1.96B +16.5% |
$1.68B +9.6% |
| Cash and Equivalents | $526.16M -32.9% |
$784.44M | — | — | — | — |
| Stockholders Equity | $4.57B +9.5% |
$4.18B +4.5% |
$4.00B +123.9% |
$1.79B +14.2% |
$1.56B +14.6% |
$1.36B |
| R&D Expense | $147.25M -10.1% |
$163.75M +32.0% |
$124.01M +69.8% |
$73.02M -25.0% |
$97.35M +15.2% |
$84.52M +40.7% |
| Operating Income | $479.82M +189.1% |
$165.99M +24.7% |
$133.14M -41.6% |
$227.95M +32.6% |
$171.95M +54.3% |
$111.43M -35.2% |
| Gross Profit | — | — | $1.02B +34.4% |
$759.12M +5.6% |
$718.88M +25.8% |
$571.58M -5.6% |
| Shares Outstanding | — | — | — | — | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $769.05M | +22.9% | +3.2% |
| Net Income | September 30, 2025 | $118.97M | +129.5% | -41.4% |
| Diluted EPS | September 30, 2025 | $0.88 | +131.6% | -40.9% |
| Total Assets | September 30, 2025 | $5.10B | +0.2% | +2.7% |
| Cash and Equivalents | September 30, 2020 | $250.61M | +50.9% | +51.4% |
| Stockholders Equity | September 30, 2025 | $4.40B | +8.1% | +2.4% |
| R&D Expense | September 30, 2025 | $38.07M | +7.6% | -4.7% |
| Operating Income | September 30, 2025 | $137.36M | +185.6% | +80.5% |
| Gross Profit | June 30, 2024 | $369.65M | +71.8% | +1.2% |
| Shares Outstanding | June 30, 2020 | 97.76M | -1.3% | -0.3% |
- GLOBUS MEDICAL INC reported Total Revenue of $2.94 billion for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +16.7% in Total Revenue compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Net Income of $537.87 million for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +422.3% in Net Income compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Diluted EPS of $3.92 per share for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +422.7% in Diluted EPS compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Total Assets of $5.30 billion for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +1.0% in Total Assets compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Cash and Equivalents of $526.16 million for fiscal year 2025.
- GLOBUS MEDICAL INC showed a decrease of -32.9% in Cash and Equivalents compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Stockholders Equity of $4.57 billion for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +9.5% in Stockholders Equity compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported R&D Expense of $147.25 million for fiscal year 2025.
- GLOBUS MEDICAL INC showed a decrease of -10.1% in R&D Expense compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Operating Income of $479.82 million for fiscal year 2025.
- GLOBUS MEDICAL INC showed an increase of +189.1% in Operating Income compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Gross Profit of $1.02 billion for fiscal year 2023.
- GLOBUS MEDICAL INC showed an increase of +34.4% in Gross Profit compared to the prior fiscal year.
- GLOBUS MEDICAL INC reported Shares Outstanding of 99.83 million shares for fiscal year 2019.
- GLOBUS MEDICAL INC showed an increase of +1.3% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: